S
600624
vs
S
Shanghai Composite
Over the past 12 months, Shanghai Fudan Forward S&T Co Ltd has underperformed Shanghai Composite, delivering a return of -33% compared to the Shanghai Composite's +23% growth.
Stocks Performance
600624 vs Shanghai Composite
Performance Gap
600624 vs Shanghai Composite
Performance By Year
600624 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shanghai Fudan Forward S&T Co Ltd
Glance View
Shanghai Fudan Forward S&T Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 1,532 full-time employees. The firm's pharmaceuticals include digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, immune function medications and others. The firm is also engaged in the provision of financial insurance software products. The company distributes its products within domestic markets and to overseas markets.
